Companies / AIM ImmunoTech Inc. / Activity
Activity — AIM ImmunoTech Inc.
9 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | Chemerow David I. Director | Grant | Common Stock | $3.4K | +3K +436.82% | 3,441 0.01% of shares | low |
| Mar 12, 2026 | Equels Thomas K CEO | Other | Common stock | $0 | +25K +64.23% | 63,922 0.21% of shares | low |
| Mar 12, 2026 | Chemerow David I. Director | Other | Common Stock | $0 | +25K +726.53% | 28,441 0.09% of shares | low |
| Mar 12, 2026 | Equels Thomas K CEO | Other | Series G Convertible Preferred Stock | — | -25 -100.00% | 0 0.00% of shares | low |
| Mar 6, 2026 | Equels Thomas K CEO | Other | Class G Warrants | — | +50K | 50,000 0.16% of shares | low |
| Mar 6, 2026 | Equels Thomas K CEO | Other | Series G Convertible Preferred Stock | — | +25 | 25 <0.01% of shares | low |
| Mar 12, 2026 | Chemerow David I. Director | Other | Series G Convertible Prefered Stock | — | -25 -100.00% | 0 0.00% of shares | low |
| Mar 6, 2026 | Chemerow David I. Director | Other | Class G Warrants | — | +50K | 50,000 0.16% of shares | low |
| Mar 6, 2026 | Chemerow David I. Director | Other | Series G Convertible Preferred Stock | — | +25 | 25 <0.01% of shares | low |